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Phage is a virus that is parasitic on bacteria. It is very important to determine the titer of test sample in 
the study of phage. In this study, an improved plating assay was developed for detection of the number 
of recombinant phage Cap-T7 present in a test solution at a certain dilution point by counting the 
plaque forming units. The data demonstrated that the improved plating assay is fast, useful, and 
convenient for the determination of the phage titer in a sample.  
 





Bacteriophage is a virus that infects and replicates within 
a bacterium; it was discovered independently by Frederick 
Twort and Félix d’Hérelle, respectively, in 1915 and 1917 
(Kaur et al., 2012). There are a wide variety of phages 
and they are among the most common and diverse 
entities in the biosphere (Clokie et al., 2011). Every 
bacterium is likely to have their own specific phage 
viruses (Flores et al., 2011; Örmälä and Jalasvuori, 2013), 
and phages play an important role in bacterial evolution 
(Labrie et al., 2010). 
Phages infect bacteria very selectively; their growth 
and proliferation are in a specific host without harming 
commensal bacterial flora (Loc-Carrillo and Abedon, 
2011). Phages have significant potential in the resistance 
to bacterial infection; they have been used for many 
years as the alternative to antibiotics in the former  Soviet 
Union and Central Europe, as well as in France (Clark 
and March, 2006). While the role of phage anti-bacterial 
infection has been ignored for many years due to all 
kinds of reasons, including the discovery of the antibiotics 
(Cui, 2015). In recent years, antibiotic-resistant bacterial 
infection has become a global concern (Zhang et al., 
2015); more and more countries presently ban the use of 
antibiotics to control bacterial infections in swine (Thacker, 
2014). Phage therapy is re-valued by researchers to 
combat the growing menace of antibiotic-resistant 
infections (Torres-Barceló and Hochberg, 2016). 
Determination of phage titer in a sample is a key step in 
the study of the phage involved. It is very important to 
select suitable dosage in the phage therapy for bacterial 
infection, to analyze the efficiency of packaging reactions 
in  vitro,  to  detect  the  number  of  primary  recombinant
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phages in a constructed library, and to monitor the 
enrichment of phage during biopanning. As a common 
method of detection, a plating assay at present is widely 
used to detect phage number present in the test samples 
at various diluted points (Sambrook and Russell, 2001); 
the results are then further used to calculate phage titer. 
According to the plating assay, the test sample from 
every one dilution at least needs one agarose plate. This 
may lead to the need of a lot of plates, waste large 
amount of reagent and consumptive materials, increase 
the experimental funds and labor. The aim of the current 
study was to develop an improved plating assay for the 




MATERIALS AND METHODS 
 
Phage and host strain  
 
The purified recombinant phage Cap-T7, conserved in Chongqing 
Academy of Animal Science Veterinary Research Institute, was 
used in the present investigation. Escherichia coli BLT5403, the 




The plating assay of phage Cap-T7 by the fixed method  
 
The plating assay is used to calculate the number of phage Cap-T7 
present in samples at various points according to the fixed protocol 
described briefly as follows: a series of dilutions of the Cap-T7 were 
prepared by adding 100 μl of the sample to 900 μl of sterile Luria-
Bertani (LB) medium. 250 μl of the host cells (OD600 = 0.8) were 
pipetted into 4 ml sterile tubes. Starting with the highest dilution, 
100 μl of the Cap-T7 dilution was added into each tube. After that, 3 
ml of autoclaved and cooled to 45°C top agarose (Bacto tryptone 1 
g, yeast extract 0.5 g, NaCl 0.5 g, agarose 0.6 g, per 100 ml) was 
added to the tubes. The contents were mixed and then poured onto 
a pre-warmed LB/carbenicillin agar plate. On the agarose spreading 
evenly and hardened, the plates were inverted and incubated at 
37°C for 4 h. Phage number in test sample was calculated by 
counting the plaque forming units (pfus) on the plate. 
 
 
Improved plating assay of phage Cap-T7 
 
Preparation of the improved agarose plate 
 
LB liquid culture (4 ml) of E. coli BLT5403 (OD600 = 0.8) were added 
into 100 ml triangular flask containing 50 ml autoclaved and cooled 
to 45°C top agarose as described earlier. The contents were 
immediately mixed and then 4 ml were taken out from the flask, and 
poured in a standard 100 × 15 mm Petri dish containing 20 ml of 
hardened LB/carbenicillin agar pre-warmed at 37°C. The plate was 
swirled gently to spread the agarose evenly. The plate was allowed 
to sit undisturbed until the top agarose was hardened, and then it 
was inverted and stored at 4°C. 
 
 
Phage incubation and its titer 
 
A series of the phage Cap-T7 dilutions were carried out as ten-fold 
dilution described earlier. After that, 5 μl solutions were taken out 
from every  phage  dilution  and  4  different  dilution  samples  were  




uniformly put in separate spots onto the surface of the improved 
agarose plate. The plate was allowed to sit undisturbed for more 
than 30 min until the 5 μl solutions become dry. Then, it was 
inverted and incubated at 37°C. Phage number in test solutions 





The data was expressed as mean ± standard deviation (SD). 
Statistical significance of the difference was analyzed using 
Student's T-Test. P-value less than 0.05 (P < 0.05) was considered 
as statistically significant. 
 
 
Plaque polymerase chain reaction (PCR) 
 
The pfus were randomly selected out to be used for subsequent 
PCR assay according to the protocol of T7Selected® System 
Manual (Novagen, Darmstadt, Germany). A set of specific primers 
were designed using software GeneTool, the forward primer is 5’-
ggc tgc agg aat tca tga ctt-3’, reverse primer is 5’-tcg ata agct tgt 
acg ggt t c-3’. Amplifications were performed with 0.5 µM of each 
primer, 0.2 mM of each dNTP and 2.0 U Taq DNA polymerase 
(TaKaRa, Dalian, China) with the following cycling parameters: 
denaturation at 94°C, 4 min; 35 cycles (94°C, 45 s; annealing at 
55°C, 40 s; 72°C, 60 s); final elongation at 72°C, 10 min. PCR 
products were then electrophoresed and the sequences were 
identified (Sangon Biotech, Shanghai, China).  
 
 




T7 phage, one of the best-studies bacterial viruses 
(Häuser et al., 2012), is a lytic phage. Its phage particle 
assembly takes place in E. coli cytoplasm and mature 
phages are released by cell lysis (Dunn and Studier, 
1983). Therefore, when the Cap-T7 was present in the 
test sample, pfu (clear area) will be observed in the lawn 
of its host E. coli BLT5403 which corresponds to 
individual phage infection event produced by single Cap-





solutions were used to 
affect bacteria for pfus counting. With the extension of 
culture time, pfus appeared to become larger and larger. 
A series of plaques were observed on the plates 
incubated at 37°C for ~4 h. The pfus in the improved 
agarose plates vary from mutual fusion to clearly 
distinguishable and numerable single unit with the 
increase of gradient dilution up to no pfus appearing at 







 dilution points, with 3 clearly 
distinguishable pfus that can be counted at the 10
-19
 
dilution point (Figure 1a). In contrast, the pfus from one of 
the plates of the fixed plating assay reflected the phage 
number of the test solution at only one dilution point. In 
this case, there were only 73 pfus in the 100 µl solution at 
the 10
-19
 dilution point (Figure 1b). Besides, some 
additional tests were also conducted to perform the 
plaque  assay using the same methods described earlier,  






Figure 1. The pfus in the agar plates incubated at 37°C for ~4 h at different dilutions. Ten-fold dilutions of 
the test sample Cap-T7 ranging from 1×10-16 to 1×10-20 solutions were used for pfus counting. As indicated 
in the agar plates, a and c showed the plaques in the improved plate at 10-17, 10-18, 10-19, 10-20 and 10-16 
10-17, 10-18, 10-19 dilutions, respectively, and 3 single plaques were observed in the 5 μl at 10-19 dilutions. b 
and d showed the plaques in the plate of fixed method at 10-19 and 10-20 dilutions, 73 and 7 single 




and similar results were obtained. For instance, they also 
have a series of plaques at different dilutions including 
the 3 single pfus at the 10
-19
 dilution point in the improved 
plate (Figure 1c) and 7 plaques at the 10
-20
 dilution point 
in the control plate (Figure 1d). Obviously, it is more 
convenient for the plaque assay using the improved 
method than that using the fixed method. 
 
 
Determination of phage titer 
 
According to the number of the single countable plaques 
on the plate, the volume of the detection, and  the dilution 
of the test sample, phage Cap-T7 titer can be easily 
calculated. For example, there were 3 plaques on a plate 
from a 10
-19
 dilution in 5 μl volume (Figure 1), then the 




 pfu/ml based 
on the improved method. Through three separate 
experiments, the titer of the phage Cap-T7 in the test 
sample was finally determined (Table 1). The phage titer 
values obtained from the improved plating assay and the 
fixed plating assay were not identical, showing certain 
degrees of variation. However, the two values (6.67 ± 
1.15 × 10
21
 and 6.93 ± 0.40 × 10
21
) have the same order 
of magnitude, and there was no statistically significant 
difference (P > 0.05) for the two test methods to determine  
 
          
 
         
 
a       b      
c      d    




Table 1. Statistical analysis of the phage titer assays. 
 
Group Dilution Spotting solutions (µl) Phage titer (pfus/ml) P-value 
The improved plating assay 10
-19
 5 6.67±1.15 × 10
21
 
P > 0.05 
The plating assay 10
-19




The values of phage titer are the average values of three determinations with standard deviation. P < 0.05, significantly different after 






Figure 2. The electrophoresis results of the 
plaque PCR production. Product length was 
727bp. M. Stand for DNA Marker, 1. PCR 
production of plaque from the plate of the 
improved plating assay, 2. PCR production of 
plaque from the plate of the common plating 




the phage titer. At the same time, the statistical analysis 
also proved that it was credible using the improved 
plating assay to determine phage titers.  
 
 
Identification of plaque forming units 
 
In order to determine the plaque forming unit authenticity 
of the recombinant phage particle, some plaques were 
selected out from the plates randomly and PCR analysis 
was conducted. The agarose gel electrophoresis map of 
the 2 plaques’ PCR production is as shown in Figure 2. 
The result showed that there was a clear DNA band 
located at about 750 bp in the gel and the molecular 
weight (MW) of PCR production of the plaques from the 
improved plating assay group and the fixed plating assay 
group was consistent with the expected length size. In 
addition, sequence identified results also verified that the 
DNA bands had the same DNA sequence  (Sequence  1). 
All proved that the phage plaques obtained from the 






In this paper, recombinant phage Cap-T7 was taken as 
the research target to improve the common plating assay 
for the detection of the number of phages present in a 
test solution by counting pfus at a certain dilution and 
easily determined the titer of the phage Cap-T7. When 
compared with the common plating assay, the improved 
plating assay showed some advantages in the 
determination of the phage titer in a sample, such as 
using less agarose plates, saving labor and time. In a 
word, improved plating assay is feasible and worth 
spreading. Finally, it should be emphasized that in order 
to obtain  the  clear,  distinguishable  and  countable  pfus  






















using the improved plating assay, more attention should 
be given to well distribute the mixture of host cells and 
melt top agarose, select appropriate volume amount of 
spotting solutions, control the incubation time, and be 
sure to replace the pipette tips between samples of 
different phage dilution to avoid cross contamination. 
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